Showing 1 - 16 results of 16 for search 'Charles R. Harrington', query time: 0.05s
Refine Results
-
1
Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease by Robert Y. K. Lai, Charles R. Harrington, Claude M. Wischik
Published 2016-04-01
Article -
2
-
3
-
4
Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks by Karima Schwab, Valeria Melis, Charles R. Harrington, Claude M. Wischik, Mandy Magbagbeolu, Franz Theuring, Gernot Riedel
Published 2021-08-01
Article -
5
-
6
Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391) by Youssra K. Al-Hilaly, Youssra K. Al-Hilaly, Connor Hurt, Janet E. Rickard, Charles R. Harrington, Charles R. Harrington, John M. D. Storey, John M. D. Storey, Claude M. Wischik, Claude M. Wischik, Louise C. Serpell, Ansgar B. Siemer
Published 2022-12-01
Article -
7
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model by Maciej Zadrozny, Patrycja Drapich, Anna Gasiorowska-Bien, Wiktor Niewiadomski, Charles R. Harrington, Claude M. Wischik, Gernot Riedel, Grazyna Niewiadomska
Published 2024-04-01
Article -
8
-
9
-
10
Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis by Alex Zabala-Findlay, Lewis K. Penny, Richard A. Lofthouse, Andrew J. Porter, Soumya Palliyil, Charles R. Harrington, Claude M. Wischik, Mohammad Arastoo
Published 2023-04-01
Article -
11
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants by Mohammad Arastoo, Michael P. Mazanetz, Sonya Miller, Helen Shiells, Claire Hull, Keith Robinson, John M. D. Storey, Charles R. Harrington, Claude M. Wischik
Published 2023-09-01
Article -
12
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy by Karima Schwab, Silke Frahm, David Horsley, Janet E. Rickard, Valeria Melis, Elizabeth A. Goatman, Mandy Magbagbeolu, Morag Douglas, Michael G. Leith, Thomas C. Baddeley, Thomas C. Baddeley, John M. D. Storey, John M. D. Storey, Gernot Riedel, Claude M. Wischik, Claude M. Wischik, Charles R. Harrington, Charles R. Harrington, Franz Theuring
Published 2018-01-01
Article -
13
HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine by Renato X. Santos, Valeria Melis, Elizabeth A. Goatman, Michael Leith, Thomas C. Baddeley, John M. D. Storey, Gernot Riedel, Claude M. Wischik, Charles R. Harrington
Published 2022-04-01
Article -
14
The Neurovascular Unit Dysfunction in Alzheimer’s Disease by Luis O. Soto-Rojas, Mar Pacheco-Herrero, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Marcos M. Villegas-Rojas, Charles R. Harrington, Fidel de la Cruz, Linda Garcés-Ramírez, José Luna-Muñoz
Published 2021-02-01
Article -
15
Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains by Luis O. Soto-Rojas, B. Berenice Campa-Córdoba, Charles R. Harrington, Andrés Salas-Casas, Mario Hernandes-Alejandro, Ignacio Villanueva-Fierro, Marely Bravo-Muñoz, Linda Garcés-Ramírez, Fidel De La Cruz-López, Miguel Ángel Ontiveros-Torres, Goar Gevorkian, Mar Pacheco-Herrero, José Luna-Muñoz
Published 2021-04-01
Article -
16
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection by Mar Pacheco-Herrero, Luis O. Soto-Rojas, Charles R. Harrington, Yazmin M. Flores-Martinez, Marcos M. Villegas-Rojas, Alfredo M. León-Aguilar, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Ricardo Apátiga-Pérez, Carolin N. Corniel-Taveras, Jesabelle de J. Dominguez-García, Víctor Manuel Blanco-Alvarez, José Luna-Muñoz, José Luna-Muñoz
Published 2021-04-01
Article